Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

di Iulio, J; Ciuffi, A; Fitzmaurice, K; Kelleher, D; Rotger, M; Fellay, J; Martinez, R; Pulit, S; Furrer, H; Günthard, H F; Battegay, M; Bernasconi, E; Schmid, P; Hirschel, B; Barnes, E; Klenerman, P; Telenti, A; Rauch, A (2011). Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology, 53(5):1446-1454.

Rohrbach, J; Robinson, N; Harcourt, G; Hammond, E; Gaudieri, S; Gorgievski, M; Telenti, A; Keiser, O; Günthard, H F; Hirschel, B; Hoffmann, M; Bernasconi, E; Battegay, M; Furrer, H; Klenerman, P; Rauch, A (2010). Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut, 59(9):1252-1258.

Rauch, A; James, I; Pfafferott, K; Nolan, D; Klenerman, P; Cheng, W; Mollison, L; McCaughan, G; Shackel, N; Jeffrey, G P; Baker, R; Freitas, E; Humphreys, I; Furrer, F; Günthard, H F; Hirschel, B; Mallal, S; John, M; Lucas, M; Barnes, E; Gaudieri, S (2009). Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology, 50(4):1017-1029.

Gaudieri, S; Rauch, A; Pfafferott, K; Barnes, E; Cheng, W; McCaughan, G; Shackel, N; Jeffrey, G P; Mollison, L; Baker, R; Furrer, H; Günthard, H F; Freitas, E; Humphreys, I; Klenerman, P; Mallal, S; James, I; Roberts, S; Nolan, D; Lucas, M (2009). Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. Hepatology, 49(4):1069-1082.

This list was generated on Sun Oct 22 03:39:57 2017 CEST.